Ottobock's Robust H1 2025 Results Driven by Innovation

In the first half of 2025, Ottobock SE & Co. KGaA reported a 5.0% increase in revenue, reaching EUR 801 million, highlighted by a significant 10.0% organic growth. The company's EBITDA rose by 30.5% to EUR 180 million, bolstered by strategic product launches and acquisitions. This growth was supported by an improvement in EBITDA margins, increased by 4.4 percentage points to 22.5%, due to favorable product mix and efficiency gains.

CEO Oliver Jakobi emphasized continued investment in advanced technologies, including prosthetics and exoskeletons, as key growth drivers. The company also introduced four strategic products and invested in start-ups to expand its technology pipeline. CFO Dr. Arne Kreitz noted Ottobock's strong financial health and optimism in achieving future targets.